
Overview
Intelliseq is a company that provides a cloud-based platform for the analysis of Next-Generation Sequencing (NGS) data and clinical interpretation. Their services include automated genomic analysis and reporting through products like iFlow™ and GeneSpect™ Reporters, which cover various medical conditions such as hereditary cancers and cardiovascular diseases. The platform is designed for ease of use, allowing users to perform analyses without needing extensive expertise.
Financials
Revenue history (in k)
Filing timeliness
2 of 5 financial statements were filed late (the longest delay 81 days for 2021). 4 of 5 audited by a statutory auditor.
- 202501/10/2026
- 202426/06/2025
- 202305/07/2024
- 202204/07/2023
- 202104/10/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Genomic data analysis
- Genetic variant interpretation
- Genetic results reporting
- Bioinformatics platform
- Pharmacogenomic analysis
- Hereditary disease diagnostics
Websites
- intelliseq.comIntelliseqCloudflare
Authorized Representatives
Manner of representation
If the company has a one-person management board, it will be represented by one member (the President) of the management board, whereas if it has a multi-member management board, it will be represented as follows: A. by two members of the management board jointly; B. notwithstanding the foregoing provisions, if a member of the management board serving as Financial Director is appointed, the company will be represented by two members of the management board acting jointly, one of whom will be the member of the management board serving as Financial Director.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-09-30.
61 1050 1445 1000 0090 8004 5660
12 1050 1445 1000 0090 8691 3754
90 1050 1445 1000 0090 3039 0935
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| May 30, 2025 | Shareholders' meeting convened | |
| Jun 3, 2024 | Shareholders' meeting convened | |
| Jun 2, 2023 | Shareholders' meeting convened |
Public aid
11 public aid cases recorded, with a total value of $3,418,000.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 4, 2022 | Aid for SME access to finance — risk finance aid | –– | PFR Ventures sp. z o.o. | |
| Nov 12, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Aug 5, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Fundacja Instytut Studiów Wschodnich |
European Funds
4 projects co-financed from European Funds recorded, with total EU co-financing of $1,880,474.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-10-01 | Development of a pharmacological genome interpretation system – PGx Plus | $869.3K$869,306 | Operational Programme Smart Growth | |
| 2019-04-08 | Promotion of Intelliseq genetic informatics products on the US market | $79,094$79,094 | Operational Programme Smart Growth | |
| 2019-01-01 | Development of an innovative technology for creating mobile applications for consumer genetics - MOBIGEN | $420.3K$420,277 | Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Genxone S.A. | $665,361.35 | genxone.eu | ||
| Precisionlife Poland sp. z o.o. | $617,020.34 | precisionlife.com | ||
| Camino Science sp. z o.o. | $557,065.18 | camino.science | ||
| GMT Foodsafety sp. z o.o. | $207,064.75 | gmtfoodsafety.com | ||
| Nexbio sp. z o.o. | $186,582.40 | nexbio.pl | ||
| Ogólnopolska Grupa Badań Społecznych sp. z o.o. | $165,934.68 | diagnoza-spoleczna.pl | ||
| Clinbit sp. z o.o. | $114,041.47 | clinbit.com | ||
| Xenstats sp. z o.o. | $66,774.27 | xenstats.com | ||
| Actn3 Bioinformatics sp. z o.o. | $34,254.75 | actn3.pl | ||
| Data2biology sp. z o.o. | $28,567.58 | data2biology.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-28 | Share capital increase (3,014,404.50 PLN → 3,032,404.50 PLN) | |
| 2025-09-19 | Share capital increase (2,930,595.50 PLN → 3,014,404.50 PLN) | |
| 2025-05-19 | Share capital increase (2,672,404.50 PLN → 2,930,595.50 PLN) | |
| 2025-02-28 | Share capital increase (1,827,409.00 PLN → 2,672,404.50 PLN) | |
| 2022-12-30 | Share capital increase (1,250,220.00 PLN → 1,827,409.00 PLN) |
FAQ
Last updated: 2026-10-03